Novartis AG ($NVS) Stock Forecast: Up 3.5% Today

What is Novartis AG?

Novartis AG (NVS) is a multinational pharmaceutical company known for its innovative healthcare products and research initiatives. The company operates in various segments, including Innovative Medicines, Sandoz, and Alcon, offering a wide range of pharmaceuticals and healthcare solutions to global markets.

Why is Novartis AG going up?

NVS stock is up 3.5% on Jan 6, 2026 19:15

• The bullish movement in Novartis AG (NVS) stock today is driven by increased institutional investment and positive sentiment from analysts following a recent earnings miss.
• Institutional investors like Eldred Rock Partners LLC and Moody Lynn & Lieberson LLC have significantly raised their stakes in NVS, reflecting confidence in the company's long-term growth.
• Analyst upgrades from firms such as JPMorgan and Bank of America have contributed to the optimistic shift in sentiment towards NVS, suggesting a potential upside in the stock price.
• Despite varied analyst ratings and a minor earnings miss, strong institutional support and positive market outlook are likely propelling the bullish momentum in Novartis AG's stock today.

NVS Price Chart

NVS Technical Analysis

NVS News

D.A. Davidson & CO. Sells 106,074 Shares of Novartis AG $NVS

D.A. Davidson & CO. reduced its stake in Novartis AG (NYSE:NVS) by 32.1% in the third quarter, selling 106,074 shares and retaining 224,547 shares valued at approximately $28.8 million. While institutional investors like Fisher, Loomis Sayles, Goldman Sachs, Envestnet, and State Street increased their holdings, analyst sentiment for Novartis is mixed, with an average "Hold" rating and a target price of $119.75. The company's stock currently trades around $138.50, and recent earnings missed consensus estimates by a narrow margin.

https://www.marketbeat.com/instant-alerts/filing-da-davidson-co-sells-106074-shares-of-novartis-ag-nvs-2026-01-05/

Eldred Rock Partners LLC Has $11.64 Million Position in Novartis AG $NVS

Eldred Rock Partners LLC significantly increased its stake in Novartis AG (NYSE:NVS) by 12.2% in the third quarter, bringing its total holdings to 90,753 shares valued at $11.64 million, making it the 18th largest holding in their portfolio. Novartis reported Q3 EPS of $2.25, narrowly missing estimates, but revenues beat expectations at $14.36 billion, an 8.5% year-over-year increase. Despite a consensus "Hold" rating from analysts with a target price below its current share price, institutional investment in Novartis remains robust, with several firms adjusting their positions.

https://www.marketbeat.com/instant-alerts/filing-eldred-rock-partners-llc-has-1164-million-position-in-novartis-ag-nvs-2026-01-01/

Moody Lynn & Lieberson LLC Acquires 16,752 Shares of Novartis AG $NVS

Moody Lynn & Lieberson LLC significantly increased its stake in Novartis AG (NYSE:NVS) by 731.8% in Q3, adding 16,752 shares to hold a total of 19,041 shares valued at approximately $2.44 million. Analyst sentiment for Novartis has recently shown a positive shift with upgrades from JPMorgan and Bank of America, though the consensus remains a "Hold" with an average target price of $119.75. The company's stock trades near its 12-month high and holds a market capitalization of around $293 billion, despite a slight miss in EPS for its last quarterly earnings.

https://www.marketbeat.com/instant-alerts/filing-moody-lynn-lieberson-llc-acquires-16752-shares-of-novartis-ag-nvs-2025-12-31/

Trending Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Up 5.6% Today

Tilray Inc. ($TLRY) Stock Forecast: Up 5.8% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Up 6.3% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Up 7.9% Today

DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Down 6.4% Today

FuelCell Energy ($FCEL) Stock Forecast: Up 5.9% Today

Shoals Technologies Group Inc. ($SHLS) Stock Forecast: Down 5.4% Today

Wingstop Inc. ($WING) Stock Forecast: Down 6.8% Today

Delta Air Lines Inc. ($DAL) Stock Forecast: Down 5.1% Today

United Continental Holdings Inc. ($UAL) Stock Forecast: Down 5.3% Today

Novartis AG Price History

29.09.2024 - NVS Stock was down 3.5%

• NVS experienced a bearish movement today despite being included in a list of stocks likely to gain on a potential Q3 earnings beat.
• The mention of Novartis alongside other companies may have caused uncertainty among investors, leading to a sell-off.
• The anticipation of earnings results tomorrow could have also contributed to profit-taking by traders, resulting in the bearish trend for NVS.
• Investors might be reevaluating their positions in NVS amidst the broader market volatility, leading to the downward movement in the stock price.

06.00.2026 - NVS Stock was up 3.5%

• The bullish movement in Novartis AG (NVS) stock today is driven by increased institutional investment and positive sentiment from analysts following a recent earnings miss.
• Institutional investors like Eldred Rock Partners LLC and Moody Lynn & Lieberson LLC have significantly raised their stakes in NVS, reflecting confidence in the company's long-term growth.
• Analyst upgrades from firms such as JPMorgan and Bank of America have contributed to the optimistic shift in sentiment towards NVS, suggesting a potential upside in the stock price.
• Despite varied analyst ratings and a minor earnings miss, strong institutional support and positive market outlook are likely propelling the bullish momentum in Novartis AG's stock today.

16.03.2024 - NVS Stock was down 1.7%

• Positive data regarding Fabhalta for a rare kidney disease may have been eclipsed by market concerns or uncertainties.
• Despite encouraging results from a phase III study, investors possibly reacted unfavorably to other influencing factors affecting Novartis.
• The recent acquisition of Alpine Immune Sciences by Vertex Pharmaceuticals might have diverted investor attention from Novartis, leading to the bearish market movement.
• The growing market presence of a Humira biosimilar, indirectly connected to Novartis, could have impacted investor sentiment towards the pharmaceutical industry as a whole, playing a role in NVS's decline.

30.08.2025 - NVS Stock was up 1.2%

• Novartis (NVS) displayed bullish movement today, potentially influenced by positive developments within its own pipeline or in the broader pharmaceutical sector.
• The recent decision by another company to halt a study on an obesity drug could have indirectly boosted Novartis, with investors viewing NVS as a more stable investment within the pharmaceutical industry.
• Investor attention may have shifted towards Novartis as a potential leader in the healthcare sector, following setbacks experienced by a competitor, potentially driving the bullish performance of NVS stock today.